Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
Professor Amanj Kurdi is Professor of Pharmacoepidemiology and Pharmacy Practice at the University of Strathclyde. His research focuses on the generation and application of real world evidence to evaluate the utilisation, effectiveness, safety, and value of medicines and healthcare interventions, with the aim of informing clinical practice, health policy, and regulatory decision making.
His work spans pharmacoepidemiology, drug utilisation research, medicines optimisation, medication safety, antimicrobial stewardship, and health services research. He has extensive expertise in the analysis of large-scale routinely collected healthcare data, including linked electronic health records, prescribing databases, hospital datasets, and national population-level resources. Using advanced epidemiological, statistical, and data science methods, his research examines prescribing quality, medication adherence and persistence, treatment outcomes, and the impact of health policies and clinical guidelines across a range of therapeutic areas.
Professor Kurdi has particular interests in antimicrobial resistance (AMR), antimicrobial stewardship, cardiovascular disease, diabetes, biologics and specialist medicines, and the use of real world data to support post-marketing surveillance and medicines safety monitoring. He leads and collaborates on national and international projects involving big data analytics, health informatics, and population health research, working closely with healthcare providers, policymakers, regulators, and academic partners.
He actively collaborates with researchers and institutions across the UK and internationally and contributes to several multidisciplinary research networks and initiatives. Through his research, he aims to improve the quality, safety, and sustainability of healthcare while strengthening the evidence base that supports medicines use and health policy decisions.
Prize And Awards
- Honorary Professor
- Recipient
- 1/6/2026
- External Examiner
- Recipient
- 24/2/2025
- Top-ranked research paper in the Seventh Excellent Paper Symposium (1st Position)
- Recipient
- 16/11/2024
- Honorary Reader in Pharmacoepidemiology and Pharmacy Practice, NHS Lanarkshire, Scotland.
- Recipient
- 1/3/2024
- Best Researcher (Poster winner)
- Recipient
- 11/2/2024
- Reproducibility Recognition by HDR UK as a member of EAVE II – Early Pandemic Evaluation and Enhanced Surveillance of COVID-19
- Recipient
- 31/1/2024
Publications
- Exploring hospital pharmacist perspectives on ethical considerations from automated patient prioritisation: a qualitative study
- Clifford David, Wall Alexa, Kurdi Amanj, Bennie Marion
- International Journal of Clinical Pharmacy (2026)
- Tocilizumab versus sarilumab among adults hospitalised with COVID-19 : target trial emulation across England and Scotland
- Zheng Bang, Kurdi Amanj, Amstutz Alain, Green Amelia, Herrett Emily, Tazare John, Wen Qing, Mahalingasivam Viyaasan, Smith Rebecca, MacKenna Brian, Mehrkar Amir, Bacon Sebastian, Goldacre Ben, Robertson Chris, Sheikh Aziz, Tomlinson Laurie
- Nature Communications (2026)
- https://doi.org/10.1038/s41467-026-73134-9
- Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system
- Hamida Jalal Abu, Alkhatib Nimer S, Hammour Khawla Abu, Halloush Shiraz, Kurdi Amanj, Balkhi Bander, Alfayez Osamah M, Mousa Rimal
- Frontiers in Public Health Vol 14 (2026)
- https://doi.org/10.3389/fpubh.2026.1800784
- UK Antimicrobial Registry:Virtual- An innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland
- Kurdi Amanj
- The 42nd ICPE Annual Meeting (2026)
- Opioid utilisation and their associated mortality in Northern Ireland
- Kurdi Amanj
- The 42nd ICPE Annual Meeting (2026)
- Antibiotic shortages among public sector hospitals across Sub-Saharan Africa : findings and implications from a pilot study
- Munzhedzi Mukhethwa, Meyer Johanna, Chigome Audrey, Miljković Nenad, Moore Catrin E, Kumar Gauri, Kurdi Amanj, Campbell Stephen M, Godman Brian
- Advances in Human Biology (2026)
Professional Activities
- Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People
- Participant
- 26/2/2026
- Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People
- Participant
- 26/2/2026
- Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
- Speaker
- 29/10/2025
- CPD course: Alkitab university pharmacy students summer school
- Organiser
- 7/7/2025
- NORDIC Social Pharmacy Conference 2025
- Organiser
- 4/6/2025
- External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
- Examiner
- 24/2/2025
Projects
- Enhancing Real-World Data Analysis Skills through Transnational Education: Bridging Global Health Knowledge and Practical Applications
- Kurdi, Amanj (Principal Investigator)
- 01-Jan-2026 - 31-Jan-2027
- Tackling antimicrobial resistance in Saudi Arabia: a multidisciplinary program to instigating evidence-based, theory-driven antimicrobial stewardship interventions using mixed-method approach
- Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
- A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K
- 01-Jan-2025 - 30-Jan-2029
- Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
- Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
- 01-Jan-2024 - 30-Jan-2025
- Cancer Medicines Outcomes Programme - Public Health Scotland
- Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
- Prescribing medicines use in pregnancy: A scoping review protocol
- Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
- Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
- 10-Jan-2024 - 14-Jan-2024
- PHS Medicines Programme
- Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
- 01-Jan-2023 - 30-Jan-2028
Contact
Professor
Amanj
Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: amanj.baker@strath.ac.uk
Tel: 548 2181